ABIN317555
antibody from antibodies-online
Targeting: FOLH1
FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN317555 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Folate Hydrolase (Prostate-Specific Membrane Antigen) 1 (FOLH1) (AA 117-351) antibody
- Antibody type
- Monoclonal
- Description
- Protein-G affinity chromatography
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 117-351
- Isotype
- IgG
- Antibody clone number
- k1H7
- Vial size
- 50 μL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing.Shelf life: one year from despatch.
Submitted references Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability.
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.
Rajasekaran SA, Christiansen JJ, Schmid I, Oshima E, Ryazantsev S, Sakamoto K, Weinstein J, Rao NP, Rajasekaran AK
Molecular cancer therapeutics 2008 Jul;7(7):2142-51
Molecular cancer therapeutics 2008 Jul;7(7):2142-51
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.
Gregor PD, Wolchok JD, Turaga V, Latouche JB, Sadelain M, Bacich D, Heston WD, Houghton AN, Scher HI
International journal of cancer 2005 Sep 1;116(3):415-21
International journal of cancer 2005 Sep 1;116(3):415-21
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.
Slovin SF
Expert opinion on therapeutic targets 2005 Jun;9(3):561-70
Expert opinion on therapeutic targets 2005 Jun;9(3):561-70
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC